Praluent vs. Livalo
See how Praluent and Livalo compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Praluent is an injectable PCSK9 inhibitor dosed every 2 or 4 weeks, while Livalo is a daily oral statin tablet.
Praluent is FDA-approved to lower the risk of heart attack, stroke, and hospitalization for unstable angina in adults with existing cardiovascular disease, a use not included on Livalo's label.
Livalo is typically tried first for high cholesterol because it's a pill, while Praluent is often added when statins alone aren't enough or aren't tolerated.
Praluent vs. Livalo Drug Summary
Praluent
Praluent is a PCSK9 inhibitor, an injectable antibody drug that lowers LDL cholesterol by helping the liver clear it from the blood. It's given as a self-administered shot under the skin every 2 or 4 weeks, usually alongside diet and statin therapy or on its own for people with certain heart conditions.
Livalo
Livalo is a statin, an oral pill that lowers LDL cholesterol by blocking an enzyme the liver uses to make it. It's taken once daily, with or without food, and is often the first medication tried for high cholesterol before injectable options are considered.
Praluent vs. Livalo Side Effects
Praluent
Livalo
Praluent vs. Livalo Dosage
Praluent
Livalo
| STAGE | DOSE | WHEN |
| Starting dose | 75 mg every 2 weeks | At the start |
| Maximum dose | 300 mg every 4 weeks | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 4 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Praluent
| STAGE | DOSE | WHEN |
| Starting dose | 75 mg every 2 weeks | At the start |
| Maximum dose | 300 mg every 4 weeks | If needed |
| Dose changes | 2 increases | As tolerated |
Livalo
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg once daily | At the start |
| Maximum dose | 4 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Praluent vs. Livalo Indications
Praluent
Praluent is approved to lower LDL cholesterol in adults on maximally tolerated statin therapy, to treat heterozygous familial hypercholesterolemia in people 8 and older, and to reduce the risk of heart attack, stroke, and hospitalization for unstable angina in adults with existing cardiovascular disease. It is not approved for homozygous familial hypercholesterolemia or for children under 8.
Add-on to statins for high LDL cholesterol
Heterozygous familial hypercholesterolemia (age 8+)
Reduces cardiovascular event risk in heart disease
Not approved for homozygous FH
Livalo
Livalo is approved as an add-on to diet to lower LDL cholesterol, total cholesterol, apolipoprotein B, and triglycerides in adults with high cholesterol or mixed dyslipidemia, and to lower LDL in heterozygous familial hypercholesterolemia in adults and children 8 and older. It is sometimes used off-label for primary prevention of atherosclerotic cardiovascular disease.
Add-on to diet for high LDL cholesterol
Heterozygous familial hypercholesterolemia (age 8+)
Lowers triglycerides and apolipoprotein B
Off-label: primary ASCVD prevention
Praluent vs. Livalo Pros and Cons
Praluent
Praluent offers proven cardiovascular event reduction and flexible dosing intervals, but it requires self-injection and has no generic alternative, which keeps its list price high. Insurance coverage often requires trying and failing statins first.
Pros
Proven to reduce heart attack and stroke risk
Dosing as infrequent as once every 4 weeks
Works for people who can't tolerate statins
Approved for HeFH down to age 8
Cons
Requires self-injection, not a pill
No generic or biosimilar version available
Roughly $500 to $640 per month without insurance, before savings programs
Livalo
Livalo is a well-tolerated statin with minimal drug interactions and decades of safety data, but it lacks Praluent's proven reduction in heart attack and stroke risk. It's taken daily as a pill, which many people find easier to manage than an injection.
Pros
Simple once-daily oral pill
Fewer drug interactions than many statins
Roughly $315 to $410 per month without insurance, before savings programs
Long safety track record since 2009
Cons
Not proven to reduce cardiovascular events
Myopathy and rhabdomyolysis risk at higher doses
Not approved for use during pregnancy
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.